Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2016 (2016), Article ID 2020915, 17 pages
http://dx.doi.org/10.1155/2016/2020915
Review Article

Treating Chronic Pain with SSRIs: What Do We Know?

1Copenhagen University, 2200 Copenhagen, Denmark
2Department of Anesthesia, Center of Head and Orthopedics, Copenhagen University Hospital, 2200 Copenhagen, Denmark

Received 7 March 2016; Revised 30 May 2016; Accepted 12 June 2016

Academic Editor: Eldon R. Tunks

Copyright © 2016 Elias Patetsos and Emilia Horjales-Araujo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Merskey and M. Bogduk, Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, IASP Press, Seattle, Wash, USA, 1994.
  2. D. D. Price, “Psychological and neural mechanisms of the affective dimension of pain,” Science, vol. 288, no. 5472, pp. 1769–1772, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Stahl, “Fibromyalgia—pathways and neurotransmitters,” Human Psychopharmacology, vol. 24, supplement 1, pp. S11–S17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Magni, C. Moreschi, S. Rigatti-Luchini, and H. Merskey, “Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain,” Pain, vol. 56, no. 3, pp. 289–297, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. L. J. Carroll, J. D. Cassidy, and P. Côté, “Depression as a risk factor for onset of an episode of troublesome neck and low back pain,” Pain, vol. 107, no. 1-2, pp. 134–139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. N. E. Rosenthal, C. M. Mazzanti, R. L. Barnett et al., “Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder,” Molecular Psychiatry, vol. 3, no. 2, pp. 175–177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Lowry, S. L. Lightman, and D. J. Nutt, “That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion,” Journal of Psychopharmacology, vol. 23, no. 4, pp. 392–400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Millan, “Serotonin (5-HT) and pain: a reappraisal of its role in the light of receptor multiplicity,” Seminars in Neuroscience, vol. 7, no. 6, pp. 409–419, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Millan, “Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice,” Pain, vol. 58, no. 1, pp. 45–61, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Millan, “Descending control of pain,” Progress in Neurobiology, vol. 66, no. 6, pp. 355–474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Hariri and A. Holmes, “Genetics of emotional regulation: the role of the serotonin transporter in neural function,” Trends in Cognitive Sciences, vol. 10, no. 4, pp. 182–191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K.-P. Lesch, U. Balling, J. Gross et al., “Organization of the human serotonin transporter gene,” Journal of Neural Transmission, vol. 95, no. 2, pp. 157–162, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Horjales-Araujo, D. Demontis, E. K. Lund et al., “Emotional modulation of muscle pain is associated with polymorphisms in the serotonin transporter gene,” Pain, vol. 154, no. 8, pp. 1469–1476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Lindstedt, J. Berrebi, E. Greayer et al., “Conditioned pain modulation is associated with common Polymorphisms in the serotonin transporter gene,” PLoS ONE, vol. 6, no. 3, Article ID e18252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Dharmshaktu, V. Tayal, and B. S. Kalra, “Efficacy of antidepressants as analgesics: a review,” Journal of Clinical Pharmacology, vol. 52, no. 1, pp. 6–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Atkinson, M. A. Slater, D. R. Wahlgren et al., “Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity,” Pain, vol. 83, no. 2, pp. 137–145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Dickens, M. Jayson, C. Sutton, and F. Creed, “The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain,” Psychosomatics, vol. 41, no. 6, pp. 490–499, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Walker, R. W. H. Walker, M. M. Robertson, and S. Stansfeld, “Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine,” Headache, vol. 38, no. 7, pp. 523–528, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Saper, S. D. Silberstein, A. E. Lake III, and M. E. Winters, “Double-blind trial of fluoxetine: chronic daily headache and migraine,” Headache, vol. 34, no. 9, pp. 497–502, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Fagius, P. O. Osterman, A. Siden, and B.-E. Wiholm, “Guullain-Barre syndrome following zimeldine treatment,” Journal of Neurology Neurosurgery and Psychiatry, vol. 48, no. 1, pp. 65–69, 1985. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Johansson and L. Von Knorring, “A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients,” Pain, vol. 7, no. 1, pp. 69–78, 1979. View at Publisher · View at Google Scholar · View at Scopus
  22. G. K. Gourlay, D. A. Cherry, M. J. Cousins, B. L. Love, J. R. Graham, and M. O. McLachlan, “A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain,” Pain, vol. 25, no. 1, pp. 35–52, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Maina, U. Albert, V. Salvi, and F. Bogetto, “Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors,” Journal of Clinical Psychiatry, vol. 65, no. 10, pp. 1365–1371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Fava, R. Judge, S. L. Hoog, M. E. Nilsson, and S. C. Koke, “Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment,” Journal of Clinical Psychiatry, vol. 61, no. 11, pp. 863–867, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Siepmann, J. Grossmann, M. Mück-Weymann, and W. Kirch, “Effects of sertraline on autonomic and cognitive functions in healthy volunteers,” Psychopharmacology, vol. 168, no. 3, pp. 293–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. F. J. Keefe, R. A. Shelby, T. J. Somers et al., “Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study,” Pain, vol. 152, no. 4, pp. 730–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Varia, E. Logue, C. O'Connor et al., “Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin,” American Heart Journal, vol. 140, no. 3, pp. 367–372, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. R. A. Lee, R. M. West, and J. D. Wilson, “The response to sertraline in men with chronic pelvic pain syndrome,” Sexually Transmitted Infections, vol. 81, no. 2, pp. 147–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. C. Engel Jr., E. A. Walker, A. L. Engel, J. Bullis, and A. Armstrong, “A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain,” Journal of Psychosomatic Research, vol. 44, no. 2, pp. 203–207, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Bech and P. Cialdella, “Citalopram in depression—meta-analysis of intended and unintended effects,” International Clinical Psychopharmacology, vol. 6, supplement 5, pp. 45–54, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Ardid, H. Marty, J. Fialip, A. M. Privat, A. Eschalier, and J. Lavarenne, “Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice,” Fundamental and Clinical Pharmacology, vol. 6, no. 2, pp. 75–82, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Aragona, L. Bancheri, D. Perinelli et al., “Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder,” European Journal of Pain, vol. 9, no. 1, pp. 33–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. H. Sindrup, U. Bjerre, A. Dejgaard, K. Brøsen, T. Aaes-Jørgensen, and L. F. Gram, “The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy,” Clinical Pharmacology and Therapeutics, vol. 52, no. 5, pp. 547–552, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Bendtsen, R. Jensen, and J. Olesen, “A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache,” Journal of Neurology Neurosurgery and Psychiatry, vol. 61, no. 3, pp. 285–290, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. C. S. Brown, A. S. Franks, J. Wan, and F. W. Ling, “Citalopram in the treatment of women with chronic pelvic pain: an open-label trial,” The Journal of Reproductive Medicine, vol. 53, no. 3, pp. 191–195, 2008. View at Google Scholar
  36. J. Nørregaard, H. Volkmann, and B. Danneskiold-Samstøe, “A randomized controlled trial of citalopram in the treatment of fibromyalgia,” Pain, vol. 61, no. 3, pp. 445–449, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Giannopoulos, M. Kosmidou, I. Sarmas et al., “Patient compliance with SSRIs and gabapentin in painful diabetic neuropathy,” Clinical Journal of Pain, vol. 23, no. 3, pp. 267–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. U. M. Anderberg, I. Marteinsdottir, and L. von Knorring, “Citalopram in patients with fibromyalgia—a randomized, double-blind, placebo-controlled study,” European Journal of Pain, vol. 4, no. 1, pp. 27–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. Verispan, Top 200 Generic Drugs by Units in 2010, Drug Topics, 2010.
  40. N. C. Gordon, P. H. Heller, R. W. Gear, and J. D. Levine, “Interactions between fluoxetine and opiate analgesia for postoperative dental pain,” Pain, vol. 58, no. 1, pp. 85–88, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. L. M. Arnold, E. V. Hess, J. I. Hudson, J. A. Welge, S. E. Berno, and P. E. Keck Jr., “A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia,” The American Journal of Medicine, vol. 112, no. 3, pp. 191–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Goldenberg, M. Mayskiy, C. Mossey, R. Ruthazer, and C. Schmid, “A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia,” Arthritis & Rheumatism, vol. 39, no. 11, pp. 1852–1859, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Colucci D'Amato, V. Pizza, T. Marmolo, E. Giordano, V. Alfano, and A. Nasta, “Fluoxetine for migraine prophylaxis: a double-blind trial,” Headache, vol. 39, no. 10, pp. 716–719, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-L. Luo, M.-Y. Zhang, W.-Y. Wu, C.-B. Li, Z. Lu, and Q.-W. Li, “A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 8, pp. 1522–1525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. B. Max, S. A. Lynch, J. Muir, S. E. Shoaf, B. Smoller, and R. Dubner, “Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy,” The New England Journal of Medicine, vol. 326, no. 19, pp. 1250–1256, 1992. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Schreiber, S. Vinokur, V. Shavelzon, C. G. Pick, E. Zahavi, and Y. Shir, “A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain,” Israel Journal of Psychiatry and Related Sciences, vol. 38, no. 2, pp. 88–94, 2001. View at Google Scholar · View at Scopus
  47. D. Xia, P. Wang, J. Chen, S. Wang, and H. Jiang, “Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome,” Chinese Medical Journal, vol. 124, no. 14, pp. 2158–2161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. I. F. Tulloch and A. M. Johnson, “The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor,” Journal of Clinical Psychiatry, vol. 53, no. 2, pp. 7–12, 1992. View at Google Scholar · View at Scopus
  49. P. M. Doraiswamy, I. Varia, C. Hellegers et al., “A randomized controlled trial of paroxetine for noncardiac chest pain,” Psychopharmacology bulletin, vol. 39, no. 1, pp. 15–24, 2006. View at Google Scholar · View at Scopus
  50. M. Langemark and J. Olesen, “Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial,” Headache, vol. 34, no. 1, pp. 20–24, 1994. View at Publisher · View at Google Scholar · View at Scopus
  51. C. A. Foster and J. Bafaloukos, “Paroxetine in the treatment of chronic daily headache,” Headache, vol. 34, no. 10, pp. 587–589, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. A. A. Patkar, P. S. Masand, S. Krulewicz et al., “A randomized, controlled, trial of controlled release paroxetine in fibromyalgia,” The American Journal of Medicine, vol. 120, no. 5, pp. 448–454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. S. H. Sindrup, L. F. Gram, K. Brøsen, O. Eshøj, and E. F. Mogensen, “The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms,” Pain, vol. 42, no. 2, pp. 135–144, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. K. A. Holroyd, J. S. Labus, F. J. O'Donnell, and G. E. Cordingley, “Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation,” Headache, vol. 43, no. 9, pp. 999–1004, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Kwasucki, A. Stepien, G. Maksymiuk, and B. Olbrych-Karpinska, “Evaluation of analgesic action of fluvoxamine compared with efficacy of imipramine and tramadol for treatment of sciatica—open trial,” Wiad Lek, vol. 55, pp. 42–50, 2002. View at Google Scholar
  56. V. Manna, F. Bolino, and L. Di Cicco, “Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine,” Headache, vol. 34, no. 1, pp. 44–49, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Turkington, J. B. F. Grant, I. N. Ferrier, N. S. K. Rao, K. R. Linsley, and A. H. Young, “A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder,” Journal of Clinical Psychiatry, vol. 63, no. 9, pp. 778–781, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Shimodozono, K. Kawahira, T. Kamishita, A. Ogata, S.-I. Tohgo, and N. Tanaka, “Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine,” International Journal of Neuroscience, vol. 112, no. 10, pp. 1173–1181, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Moore, H. Verdoux, and B. Fantino, “Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder,” International Clinical Psychopharmacology, vol. 20, no. 3, pp. 131–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Sánchez, “The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram,” Basic and Clinical Pharmacology and Toxicology, vol. 99, no. 2, pp. 91–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Mazza, O. Mazza, C. Pazzaglia, L. Padua, and S. Mazza, “Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain,” Expert Opinion on Pharmacotherapy, vol. 11, no. 7, pp. 1049–1052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. J. E. Muller, I. Wentzel, L. Koen, D. J. H. Niehaus, S. Seedat, and D. J. Stein, “Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial,” International Clinical Psychopharmacology, vol. 23, no. 1, pp. 43–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Otto, F. W. Bach, T. S. Jensen, K. Brøsen, and S. H. Sindrup, “Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial,” Pain, vol. 139, no. 2, pp. 275–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Villemure, B. M. Slotnick, and M. C. Bushnell, “Effects of odors on pain perception: deciphering the roles of emotion and attention,” Pain, vol. 106, no. 1-2, pp. 101–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Kenntner-Mabiala and P. Pauli, “Affective modulation of brain potentials to painful and nonpainful stimuli,” Psychophysiology, vol. 42, no. 5, pp. 559–567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Roy, M. Piché, J.-I. Chen, I. Peretz, and P. Rainville, “Cerebral and spinal modulation of pain by emotions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 49, pp. 20900–20905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. W. Meagher, R. C. Arnau, and J. L. Rhudy, “Pain and emotion: effects of affective picture modulation,” Psychosomatic Medicine, vol. 63, no. 1, pp. 79–90, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. M. K. Boettger, C. Schwier, and K.-J. Bär, “Sad mood increases pain sensitivity upon thermal grill illusion stimulation: implications for central pain processing,” Pain, vol. 152, no. 1, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Horjales-Araujo, N. B. Finnerup, T. S. Jensen, and P. Svensson, “Differential effect of visual and gustatory stimuli on experimental jaw muscle pain,” European Journal of Pain, vol. 17, no. 6, pp. 811–819, 2013. View at Publisher · View at Google Scholar · View at Scopus